))
Doc2Doc Podcast August 2024: Gene Therapy
Manage episode 433834992 series 3528751
Contenuto fornito da EyeCare Partners. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da EyeCare Partners o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
This month's Doc2Doc Podcast focuses on gene therapy in eye care. Our guests are Kimberly, Drenser, M.D., Ph.D., an ophthalmologist at Associated Retinal Consultants; and Robert Sisk, M.D., FACS, an ophthalmologist at Cincinnati Eye Institute. They are featured along with hosts Albert Cheung, M.D., ophthalmologist at Virginia Eye Consultants, and Sara Lemay, OD, optometrist at Retina Associates of Kentucky.
Gene therapy in eye care is a cutting-edge approach that involves modifying or manipulating genes to potentially treat or prevent various eye diseases. This therapy holds significant promise for conditions that were previously considered untreatable or that have limited treatment options. This month's discussion includes the only currently U.S. FDA-approved gene therapy and other potential future options in the research pipeline.
28 episodi
Condividi
